Analysis of websites containing novartispharmaceuticals.com backlinks

EXTAVIA is a disease-modifying therapy (DMT) for people with relapsing forms of multiple sclerosis (MS). Learn about multiple sclerosis treatment and therapy.

~50% of all heart failure patients die by 5 years of diagnosis¹. Healthcare professionals, find out more on www.heartfailure.com

Learn about COSENTYX (secukinumab), the first fully human IL-17A antagonist approved for plaque psoriasis, psoriatic arthritis, andankylosing spondylitis.

Explore stories about how Novartis innovation has impacted people worldwide.

Learn more about Gilenya, a sphingosine 1-phosphate receptor modulator indicated for the treatment of patients with relapsing-remitting MS. See ISI for details.

Personally, I feel to ignore the intersection between health care and social media is to potentially ignore our own relevance as a health care practitioner during the next decade ~ Howard Luks, MD orthopedic surgeon and digital media and medicine specialist. Beyond The Buzz Healthcare social media is more than just a marketing buzzword; as…

Learn about ENTRESTO (sacubitril/valsartan), the HFrEF treatment for patients with chronic heart failure (NYHA Class II–IV) and reduced ejection fraction.